HEADER HYDROLASE 11-AUG-05 2BZ6 TITLE ORALLY AVAILABLE FACTOR7A INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: BLOOD COAGULATION FACTOR VIIA; COMPND 3 CHAIN: H; COMPND 4 FRAGMENT: FACTOR VII HEAVY CHAIN, RESIDUES 213-466; COMPND 5 SYNONYM: SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA, COMPND 6 PROCONVERTIN, EPTACOG ALFA, NOVOSEVEN; COMPND 7 EC: 3.4.21.21; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: BLOOD COAGULATION FACTOR VIIA; COMPND 11 CHAIN: L; COMPND 12 FRAGMENT: FACTOR VII LIGHT CHAIN, RESIDUES 150-202; COMPND 13 SYNONYM: SERUM PROTHROMBIN CONVERSION ACCELERATOR, SPCA, COMPND 14 PROCONVERTIN, EPTACOG ALFA, NOVOSEVEN; COMPND 15 EC: 3.4.21.21; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SERINE PROTEASE, COAGULATION, ENZYME COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR K.GROEBKE-ZBINDEN,U.OBST-SANDER,K.HILPERT,H.KUEHNE,D.W.BANNER, AUTHOR 2 H.J.BOEHM,M.STAHL,J.ACKERMANN,L.ALIG,L.WEBER,H.P.WESSEL, AUTHOR 3 M.A.RIEDERER,T.B.TSCHOPP,T.LAVE REVDAT 6 09-OCT-24 2BZ6 1 LINK REVDAT 5 13-JUL-11 2BZ6 1 VERSN REVDAT 4 24-FEB-09 2BZ6 1 VERSN REVDAT 3 09-AUG-06 2BZ6 1 JRNL REVDAT 2 22-MAR-06 2BZ6 1 JRNL REVDAT 1 22-FEB-06 2BZ6 0 JRNL AUTH K.GROEBKE-ZBINDEN,D.W.BANNER,K.HILPERT,J.HIMBER,T.LAVE, JRNL AUTH 2 M.A.RIEDERER,M.STAHL,T.B.TSCHOPP,U.OBST-SANDER JRNL TITL DOSE-DEPENDANT ANTITHROMBOTIC ACTIVITY OF AN ORALLY ACTIVE JRNL TITL 2 TISSUE FACTOR/FACTOR VIIA INHIBITOR WITHOUT CONCOMITANT JRNL TITL 3 ENHANCEMENT OF BLEEDING PROPENSITY. JRNL REF BIOORG.MED.CHEM. V. 14 5357 2006 JRNL REFN ISSN 0968-0896 JRNL PMID 16621574 JRNL DOI 10.1016/J.BMC.2006.03.042 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 73.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 90.2 REMARK 3 NUMBER OF REFLECTIONS : 58180 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.166 REMARK 3 FREE R VALUE : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3045 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.64 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4720 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2530 REMARK 3 BIN FREE R VALUE SET COUNT : 253 REMARK 3 BIN FREE R VALUE : 0.2740 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2370 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 500 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 22.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.77 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.51000 REMARK 3 B22 (A**2) : -0.51000 REMARK 3 B33 (A**2) : 1.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.071 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.074 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.048 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.579 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.966 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2562 ; 0.012 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2284 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3508 ; 1.462 ; 1.970 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5313 ; 0.809 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 325 ; 6.355 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;30.692 ;23.178 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 407 ;12.051 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;17.793 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 382 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2898 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 526 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 464 ; 0.218 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2421 ; 0.193 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1205 ; 0.174 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1567 ; 0.081 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 351 ; 0.187 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 5 ; 0.076 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 45 ; 0.191 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 20 ; 0.160 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2035 ; 0.904 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2572 ; 1.062 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1152 ; 1.660 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 936 ; 2.266 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : L 90 L 142 REMARK 3 ORIGIN FOR THE GROUP (A): 41.3280 27.2820 42.3810 REMARK 3 T TENSOR REMARK 3 T11: -0.0557 T22: 0.0339 REMARK 3 T33: -0.0375 T12: 0.0118 REMARK 3 T13: 0.0082 T23: 0.0079 REMARK 3 L TENSOR REMARK 3 L11: 4.6275 L22: 0.8105 REMARK 3 L33: 0.6293 L12: -0.1156 REMARK 3 L13: -0.3925 L23: 0.1547 REMARK 3 S TENSOR REMARK 3 S11: 0.0454 S12: 0.1404 S13: 0.3046 REMARK 3 S21: -0.0432 S22: -0.0125 S23: -0.0703 REMARK 3 S31: -0.0375 S32: 0.0693 S33: -0.0329 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : H 16 H 257 REMARK 3 ORIGIN FOR THE GROUP (A): 19.6170 34.6540 38.2180 REMARK 3 T TENSOR REMARK 3 T11: -0.0410 T22: 0.0070 REMARK 3 T33: -0.0808 T12: -0.0002 REMARK 3 T13: -0.0070 T23: -0.0042 REMARK 3 L TENSOR REMARK 3 L11: 0.9350 L22: 1.0137 REMARK 3 L33: 0.8568 L12: -0.0545 REMARK 3 L13: 0.2156 L23: -0.0999 REMARK 3 S TENSOR REMARK 3 S11: -0.0029 S12: 0.1156 S13: 0.0352 REMARK 3 S21: -0.0509 S22: -0.0037 S23: 0.0209 REMARK 3 S31: -0.0851 S32: 0.0283 S33: 0.0066 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2BZ6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-AUG-05. REMARK 100 THE DEPOSITION ID IS D_1290025286. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-FEB-00 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM1A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH MAR300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 69242 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.6 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.1500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 36.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : 0.81000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.780 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: ISOMORPHOUS TO 1W7X.PDB REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 35%AS, 2%PEG400, 100MM BICINE PH8.5, REMARK 280 15% GLYCEROL, PH 8.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.82000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 47.46500 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 47.46500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 28.91000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 47.46500 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 47.46500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 86.73000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 47.46500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.46500 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 28.91000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 47.46500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.46500 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 86.73000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 57.82000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH H2100 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU H 236 O HOH H 2357 1.84 REMARK 500 NE2 GLN H 239 O HOH H 2361 2.02 REMARK 500 O HOH H 2263 O HOH H 2264 2.09 REMARK 500 SG CYS H 220 O HOH H 2325 2.13 REMARK 500 O HOH H 2047 O HOH H 2076 2.16 REMARK 500 O HOH H 2072 O HOH L 2009 2.18 REMARK 500 O TRP H 61 O HOH H 2104 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS H 71 -72.17 -146.45 REMARK 500 THR H 129C -58.08 -121.79 REMARK 500 SER H 170H 139.37 -36.88 REMARK 500 SER H 214 -65.71 -122.05 REMARK 500 GLN L 100 -104.46 -124.04 REMARK 500 THR L 108 49.86 -78.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH H2001 DISTANCE = 6.40 ANGSTROMS REMARK 525 HOH H2030 DISTANCE = 5.84 ANGSTROMS REMARK 525 HOH H2033 DISTANCE = 7.78 ANGSTROMS REMARK 525 HOH H2038 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH H2066 DISTANCE = 6.70 ANGSTROMS REMARK 525 HOH H2128 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH L2012 DISTANCE = 6.74 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA H1260 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU H 70 OE1 REMARK 620 2 ASP H 72 O 85.4 REMARK 620 3 GLU H 75 O 133.1 76.9 REMARK 620 4 GLU H 80 OE2 111.7 161.0 85.0 REMARK 620 5 HOH H2122 O 80.7 98.2 59.9 77.5 REMARK 620 6 HOH H2139 O 105.7 78.8 112.7 103.2 172.6 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 H1259 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA H1260 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 346 H1258 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BF9 RELATED DB: PDB REMARK 900 N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES REMARK 900 RELATED ID: 1CVW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR REMARK 900 VIIA (DES-GLA) REMARK 900 RELATED ID: 1DAN RELATED DB: PDB REMARK 900 COMPLEX OF ACTIVE SITE INHIBITED HUMAN BLOOD COAGULATION FACTOR REMARK 900 VIIA WITH HUMAN RECOMBINANT SOLUBLE TISSUE FACTOR REMARK 900 RELATED ID: 1DVA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE REMARK 900 INHIBITOR E-76 AND COAGULATION FACTOR VIIA REMARK 900 RELATED ID: 1F7E RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, REMARK 900 20 STRUCTURES REMARK 900 RELATED ID: 1F7M RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, NMR, REMARK 900 MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1FAK RELATED DB: PDB REMARK 900 HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA REMARK 900 INHIBITED WITH A BPTI-MUTANT REMARK 900 RELATED ID: 1FF7 RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII REMARK 900 (FUCOSYLATED AT SER-60), NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1FFM RELATED DB: PDB REMARK 900 THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII REMARK 900 (FUCOSYLATED AT SER-60), NMR, MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1J9C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX REMARK 900 RELATED ID: 1JBU RELATED DB: PDB REMARK 900 COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE ) IN COMPLEXWITH REMARK 900 INHIBITORY EXOSITE PEPTIDE A -183 REMARK 900 RELATED ID: 1KLI RELATED DB: PDB REMARK 900 COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA REMARK 900 RELATED ID: 1KLJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF UNINHIBITED FACTOR VIIA REMARK 900 RELATED ID: 1NL8 RELATED DB: PDB REMARK 900 THEORETICAL MODEL OF THE TISSUE FACTOR/ FACTOR VIIA/FACTORXA COMPLEX REMARK 900 RELATED ID: 1O5D RELATED DB: PDB REMARK 900 DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTSAT THE REMARK 900 S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190UPA) REMARK 900 RELATED ID: 1QFK RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE REMARK 900 TRIGGERING OF BLOOD COAGULATION REMARK 900 RELATED ID: 1W0Y RELATED DB: PDB REMARK 900 TF7A_3771 COMPLEX REMARK 900 RELATED ID: 1W2K RELATED DB: PDB REMARK 900 TF7A_4380 COMPLEX REMARK 900 RELATED ID: 1W7X RELATED DB: PDB REMARK 900 FACTOR7 - 413 COMPLEX REMARK 900 RELATED ID: 1W8B RELATED DB: PDB REMARK 900 FACTOR7 - 413 COMPLEX REMARK 900 RELATED ID: 1YGC RELATED DB: PDB REMARK 900 SHORT FACTOR VIIA WITH A SMALL MOLECULE INHIBITOR REMARK 900 RELATED ID: 1Z6J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTORVIIA/TISSUE FACTOR/ REMARK 900 PYRAZINONE INHIBITOR DBREF 2BZ6 H 16 257 UNP P08709 FA7_HUMAN 213 466 DBREF 2BZ6 L 90 142 UNP P08709 FA7_HUMAN 150 202 SEQRES 1 H 254 ILE VAL GLY GLY LYS VAL CYS PRO LYS GLY GLU CYS PRO SEQRES 2 H 254 TRP GLN VAL LEU LEU LEU VAL ASN GLY ALA GLN LEU CYS SEQRES 3 H 254 GLY GLY THR LEU ILE ASN THR ILE TRP VAL VAL SER ALA SEQRES 4 H 254 ALA HIS CYS PHE ASP LYS ILE LYS ASN TRP ARG ASN LEU SEQRES 5 H 254 ILE ALA VAL LEU GLY GLU HIS ASP LEU SER GLU HIS ASP SEQRES 6 H 254 GLY ASP GLU GLN SER ARG ARG VAL ALA GLN VAL ILE ILE SEQRES 7 H 254 PRO SER THR TYR VAL PRO GLY THR THR ASN HIS ASP ILE SEQRES 8 H 254 ALA LEU LEU ARG LEU HIS GLN PRO VAL VAL LEU THR ASP SEQRES 9 H 254 HIS VAL VAL PRO LEU CYS LEU PRO GLU ARG THR PHE SER SEQRES 10 H 254 GLU ARG THR LEU ALA PHE VAL ARG PHE SER LEU VAL SER SEQRES 11 H 254 GLY TRP GLY GLN LEU LEU ASP ARG GLY ALA THR ALA LEU SEQRES 12 H 254 GLU LEU MET VAL LEU ASN VAL PRO ARG LEU MET THR GLN SEQRES 13 H 254 ASP CYS LEU GLN GLN SER ARG LYS VAL GLY ASP SER PRO SEQRES 14 H 254 ASN ILE THR GLU TYR MET PHE CYS ALA GLY TYR SER ASP SEQRES 15 H 254 GLY SER LYS ASP SER CYS LYS GLY ASP SER GLY GLY PRO SEQRES 16 H 254 HIS ALA THR HIS TYR ARG GLY THR TRP TYR LEU THR GLY SEQRES 17 H 254 ILE VAL SER TRP GLY GLN GLY CYS ALA THR VAL GLY HIS SEQRES 18 H 254 PHE GLY VAL TYR THR ARG VAL SER GLN TYR ILE GLU TRP SEQRES 19 H 254 LEU GLN LYS LEU MET ARG SER GLU PRO ARG PRO GLY VAL SEQRES 20 H 254 LEU LEU ARG ALA PRO PHE PRO SEQRES 1 L 53 ILE CYS VAL ASN GLU ASN GLY GLY CYS GLU GLN TYR CYS SEQRES 2 L 53 SER ASP HIS THR GLY THR LYS ARG SER CYS ARG CYS HIS SEQRES 3 L 53 GLU GLY TYR SER LEU LEU ALA ASP GLY VAL SER CYS THR SEQRES 4 L 53 PRO THR VAL GLU TYR PRO CYS GLY LYS ILE PRO ILE LEU SEQRES 5 L 53 GLU HET 346 H1258 54 HET SO4 H1259 5 HET CA H1260 1 HETNAM 346 (R)-(4-CARBAMIMIDOYL-PHENYLAMINO)-[5-ETHOXY-2-FLUORO-3- HETNAM 2 346 [(R)-TETRAHYDRO-FURAN-3-YLOXY]-PHENYL]-ACETIC ACID HETNAM SO4 SULFATE ION HETNAM CA CALCIUM ION HETSYN 346 (2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2- HETSYN 2 346 FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETIC HETSYN 3 346 ACID FORMUL 3 346 C21 H24 F N3 O5 FORMUL 4 SO4 O4 S 2- FORMUL 5 CA CA 2+ FORMUL 6 HOH *500(H2 O) HELIX 1 1 ALA H 55 ASP H 60 5 6 HELIX 2 2 ASN H 60D ARG H 62 5 3 HELIX 3 3 GLU H 125 THR H 129C 1 8 HELIX 4 4 LEU H 129D VAL H 129G 5 4 HELIX 5 5 MET H 164 SER H 170B 1 9 HELIX 6 6 CYS H 191 SER H 195 5 5 HELIX 7 7 TYR H 234 ARG H 243 1 10 HELIX 8 8 ASN L 93 CYS L 98 5 6 SHEET 1 HA 9 LYS H 20 VAL H 21 0 SHEET 2 HA 9 MET H 156 LEU H 163 -1 O VAL H 157 N LYS H 20 SHEET 3 HA 9 MET H 180 ALA H 183 -1 O CYS H 182 N LEU H 163 SHEET 4 HA 9 GLY H 226 ARG H 230 -1 O GLY H 226 N ALA H 183 SHEET 5 HA 9 THR H 206 TRP H 215 -1 O ILE H 212 N THR H 229 SHEET 6 HA 9 PRO H 198 TYR H 203 -1 O HIS H 199 N THR H 210 SHEET 7 HA 9 PHE H 135 GLY H 140 -1 O LEU H 137 N ALA H 200 SHEET 8 HA 9 MET H 156 LEU H 163 1 O MET H 156 N GLY H 140 SHEET 9 HA 9 LYS H 20 VAL H 21 -1 O LYS H 20 N VAL H 157 SHEET 1 HB 9 GLN H 30 VAL H 35 0 SHEET 2 HB 9 ALA H 39 LEU H 46 -1 O ALA H 39 N VAL H 35 SHEET 3 HB 9 TRP H 51 SER H 54 -1 O VAL H 53 N THR H 45 SHEET 4 HB 9 ALA H 104 LEU H 108 -1 O ALA H 104 N SER H 54 SHEET 5 HB 9 GLN H 81 PRO H 91 1 N ALA H 86 O ARG H 107 SHEET 6 HB 9 LEU H 64 LEU H 68 -1 O LEU H 64 N VAL H 85 SHEET 7 HB 9 GLN H 30 VAL H 35 -1 O LEU H 32 N VAL H 67 SHEET 8 HB 9 ALA H 39 LEU H 46 -1 O ALA H 39 N VAL H 35 SHEET 9 HB 9 GLN H 30 VAL H 35 -1 O VAL H 31 N GLY H 44 SHEET 1 LA 2 TYR L 101 HIS L 105 0 SHEET 2 LA 2 LYS L 109 ARG L 113 -1 O LYS L 109 N HIS L 105 SHEET 1 LB 2 TYR L 118 LEU L 120 0 SHEET 2 LB 2 CYS L 127 PRO L 129 -1 O THR L 128 N SER L 119 SSBOND 1 CYS H 22 CYS H 27 1555 1555 2.04 SSBOND 2 CYS H 42 CYS H 58 1555 1555 2.04 SSBOND 3 CYS H 122 CYS L 135 1555 1555 2.02 SSBOND 4 CYS H 168 CYS H 182 1555 1555 2.04 SSBOND 5 CYS H 191 CYS H 220 1555 1555 2.04 SSBOND 6 CYS L 91 CYS L 102 1555 1555 2.05 SSBOND 7 CYS L 98 CYS L 112 1555 1555 2.04 SSBOND 8 CYS L 114 CYS L 127 1555 1555 2.05 LINK OE1 GLU H 70 CA CA H1260 1555 1555 2.34 LINK O ASP H 72 CA CA H1260 1555 1555 2.57 LINK O GLU H 75 CA CA H1260 1555 1555 2.51 LINK OE2 GLU H 80 CA CA H1260 1555 1555 2.59 LINK CA CA H1260 O HOH H2122 1555 1555 3.11 LINK CA CA H1260 O HOH H2139 1555 1555 3.25 CISPEP 1 PHE H 256 PRO H 257 0 0.63 SITE 1 AC1 8 MET H 164 THR H 165 ARG H 230 HOH H2401 SITE 2 AC1 8 HOH H2402 HOH H2403 HOH H2404 HOH H2405 SITE 1 AC2 4 GLU H 70 ASP H 72 GLU H 75 GLU H 80 SITE 1 AC3 17 HIS H 57 THR H 98 THR H 99 ASP H 102 SITE 2 AC3 17 ASP H 189 SER H 190 LYS H 192 SER H 195 SITE 3 AC3 17 SER H 214 TRP H 215 GLY H 216 GLN H 217 SITE 4 AC3 17 GLY H 219 HOH H2340 HOH H2348 HOH H2395 SITE 5 AC3 17 HOH H2398 CRYST1 94.930 94.930 115.640 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010534 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010534 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008648 0.00000